Localization in China – Consider Opportunities and Include Financing
Given the current dynamics at play, many companies have no choice but to further localize their value-added activities in China. The Chamber of Industry and Commerce (IHK) refers to this as “Localization 3.0.” Key forces drive localization The figure illustrates the key factors influencing localization in China: The fields appear to be interdependent because: For […]
Joint venture China, subsidiary (WFOE) or hybrid?
By Frank-Christan Raffel Frank-Christian Raffel has been analyzing and shaping the strategy and corporate form of European companies in China and Southeast Asia since 1997, when he conducted a broad-based study in cooperation with the Hong Kong and Shanghai Chambers of Commerce. It is remarkable how often we hear the question even today, in the […]
MRL Advisors takes a stake in EMTS Group Pte. Ltd. in Singapore and Manila
By Frank-Christian Raffel EMTS – European Medtech Services – has set itself the goal of improving the availability of medical technology in Southeast Asia. MRL Advisors has joined as a founding partner. The former top manager of the Austrian Fresenius-VAMED, Matthias Köhler, had the idea to found the company when Southeast Asia was no longer […]
Dr. Franz Köhler Chemie: Establishment of its own subsidiary in China with an innovative shareholder model
By Frank-Christian Raffel Dr. Franz Köhler Chemie (DFKC) is a research-intensive and innovative pharmaceutical company and is owner-managed in the third generation. DFKC is, among other things, the manufacturer of the organ-protective solution CUSTODIOL©, which is distributed worldwide by DFKC. Starting Point China is one of the most important markets in the world for DFKC. […]